Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Neoplasm Malignant Resectable”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT03649035
What this trial is testing

Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPancreatic CancerPancreas Neoplasm
Istituto Clinico Humanitas
Not applicableActive Not RecruitingNCT05479708
What this trial is testing

CtDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer Resectable
BAIYONG SHEN 150
Not applicableStudy completedNCT03340844
What this trial is testing

Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors

Who this might be right for
Pancreatic TumorPeriampullary Carcinoma ResectableCirculating Tumor Cells+1 more
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 86
Not applicableLooking for participantsNCT06914349
What this trial is testing

Antecolic Versus Retrocolic Gastrojejunostomy During Whipple's Procedure

Who this might be right for
Pancreatic Cancer ResectablePancreas Neoplasms
University of Thessaly 76
Testing effectiveness (Phase 2)Looking for participantsNCT03977233
What this trial is testing

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Cancer of PancreasPancreatic Cancer, Adult+4 more
UNC Lineberger Comprehensive Cancer Center 45
Not applicableLooking for participantsNCT07022015
What this trial is testing

Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy

Who this might be right for
Pancreas CancerPancreas NeoplasmPancreatic Fistula+4 more
Minia University 100
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Not applicableLooking for participantsNCT06388967
What this trial is testing

Pancreatic Cancer Detection Consortium

Who this might be right for
Pancreatic CancerPancreatic CarcinomaPancreatic Adenocarcinoma+10 more
City of Hope Medical Center 2,000
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableActive Not RecruitingNCT07157605
What this trial is testing

Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)

Who this might be right for
Pancreatic Cancer ResectablePancreatectomy
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 94
Not applicableStudy completedNCT07184047
What this trial is testing

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersFrailtySarcopenia in Elderly+8 more
Ankara Etlik City Hospital 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05810792
What this trial is testing

Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerSurgeryMetastasis+1 more
Sahlgrenska University Hospital 50
Post-approval studies (Phase 4)Ended earlyNCT01887041
What this trial is testing

Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer

Who this might be right for
Local Tumor SpreadAdvanced CancerMetastasized+2 more
Universitätsklinikum Hamburg-Eppendorf 24
Not applicableUnknownNCT04736043
What this trial is testing

Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid

Who this might be right for
Pancreatic Cancer Resectable
Samsung Medical Center 300
Testing effectiveness (Phase 2)Ended earlyNCT03344172
What this trial is testing

Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Nathan Bahary, MD 32
Early research (Phase 1)Study completedNCT01903083
What this trial is testing

Chemoimmunotherapy and Radiation in Pancreatic Cancer

Who this might be right for
Locally Advanced Malignant Neoplasm
Providence Health & Services 10
Testing effectiveness (Phase 2)Looking for participantsNCT06722911
What this trial is testing

Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Zhejiang Provincial People's Hospital 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469956
What this trial is testing

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Sun Yat-sen University 30
Not applicableNot Yet RecruitingNCT06941987
What this trial is testing

Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer

Who this might be right for
Minimal Residual DiseasePancreatic Cancer Resectable
Shanghai Zhongshan Hospital 66
Not applicableStudy completedNCT06809374
What this trial is testing

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Kochi University 100
Next Page